BioRestorative Therapies, Inc. BRTX
1.58 USD +0.06 (+3.95%)
Nov 9, 2026, 3:22 PM EST
1.52 Day range 1.59
1.28 52-week range 29.00
- YTD
- +35.04%
- 1 year
- +15.33%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 359.70K | 401.00K | 145.80K | 119.80K | 46.00K | |
| 335.86K | 372.93K | 145.80K | 119.80K | 46.00K | |
| -15.65M | -11.56M | -15.22M | -18.97M | -26.31M | |
| -14.24M | -8.98M | -10.42M | -13.22M | -44.30M | |
| -31.60 | -23.20 | -49.40 | -73.00 | -746.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.51M | 547.89K | 884.38K | 1.71M | 21.03M | |
| 4.08M | 12.28M | 12.61M | 16.43M | 22.45M | |
| 3.72M | 3.75M | 2.61M | 6.14M | 856.50K | |
| 356.74K | 8.53M | 10.00M | 10.29M | 21.60M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -10.79M | -8.23M | -6.43M | -5.91M | -3.33M | |
| 8.90M | 514.53K | 3.25M | -13.40M | -30.66K | |
| 2.85M | 7.38M | 2.35M | 0 | 21.32M | |
| -116.07K | -106.19K | -171.04K | -265.22K | -30.66K | |
| 963.30K | -336.49K | -829.39K | -19.31M | 17.96M |